A study conducted by Zhou et al. demonstrated that the PI3K/AKT/mTOR pathway is more significantly activated in high-grade HCC tumors and is associated with poor prognosis in HCC patients [8], suggesting that the activation of the PI3K/AKT/mTOR pathway functionally contributes to HCC progression. The gene discussed is MTOR; the disease is hepatocellular carcinoma.